Skip to main content
. 2020 Aug;10(4):752–769. doi: 10.21037/cdt-19-707

Figure 5.

Figure 5

Effect of Cur on myocardial echocardiographic properties and plasma cTnI level in DOX-treated mice. (A) Heart rate; (B) LV posterior wall thickness in diastole; (C) LV end diastolic diameter (LVEDD); (D) LV end systolic diameter (LVESD); (E) fractional shortening; (F) ejection fraction; and (G) cardiac troponin I (cTnI). Mean ± SD; n=6–8 mice per group, *, P<0.05 between the indicated groups. Con, Control group; DOX, DOX group; Con-Cur [50], 50 mg·kg−1 Cur treatment in control group; DOX-Cur [50], DOX with Cur treatment at 50 mg·kg−1; Con-Cur [100], 100 mg·kg−1 Cur treatment in control group; DOX-Cur [100], DOX with Cur treatment at 100 mg·kg−1.